Shota Omori

Rebiopsy for patients with non‐small‐cell lung cancer after epidermal growth factor receptor‐tyrosine kinase inhibitor failure

Takahisa Kawamura, Hirotsugu Kenmotsu, Tetsuhiko Taira et al. · Cancer Science · 2016 · 92 citations · Full text

Medicine, Oncology, Pathology +15

Skeletal muscle depletion during chemotherapy has a large impact on physical function in elderly Japanese patients with advanced non–small-cell lung cancer

Tateaki Naito, Taro Okayama, Takashi Aoyama et al. · BMC Cancer · 2017 · 77 citations · Full text

Medicine, Geriatric Medicine, Oncology +15

A Randomized Phase II Study Comparing Nivolumab with Carboplatin–Pemetrexed for <i>EGFR</i> -Mutated NSCLC with Resistance to EGFR Tyrosine Kinase Inhibitors (WJOG8515L)

Hidetoshi Hayashi, Shunichi Sugawara, Yasushi Fukuda et al. · Clinical Cancer Research · 2021 · 76 citations · Full text

Medicine, Oncology, Pharmacology +17

Real‐world data on NGS using the Oncomine DxTT for detecting genetic alterations in non‐small‐cell lung cancer: WJOG13019L

Shinya Sakata, Kohei Otsubo, Hisako Yoshida et al. · Cancer Science · 2021 · 71 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Unfavorable impact of cancer cachexia on activity of daily living and need for inpatient care in elderly patients with advanced non-small-cell lung cancer in Japan: a prospective longitudinal observational study

Tateaki Naito, Taro Okayama, Takashi Aoyama et al. · BMC Cancer · 2017 · 63 citations · Full text

Medicine, Geriatric Medicine, Oncology +17